Algorae Pharmaceuticals Limited (ASX:1AI)
Australia
· Delayed Price · Currency is AUD 0.0130
-0.0010 (-7.14%)
Mar 10, 2026, 4:10 PM AEST
Algorae Pharmaceuticals Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1.13 | 0.47 | 0.81 | 2.09 | 4.24 | 1.57 | Upgrade
|
| Short-Term Investments | 0.75 | 1.85 | 2.3 | 2.02 | - | 0.04 | Upgrade
|
| Cash & Short-Term Investments | 1.88 | 2.32 | 3.11 | 4.11 | 4.24 | 1.61 | Upgrade
|
| Cash Growth | -21.76% | -25.39% | -24.39% | -3.02% | 162.92% | -45.62% | Upgrade
|
| Accounts Receivable | 0.03 | 0 | 0.03 | 0.01 | - | - | Upgrade
|
| Other Receivables | - | 0.04 | 0.01 | 0.09 | 0.03 | 0.01 | Upgrade
|
| Receivables | 0.03 | 0.04 | 0.04 | 0.1 | 0.03 | 0.01 | Upgrade
|
| Other Current Assets | 0.09 | 0.04 | 0.04 | - | - | - | Upgrade
|
| Total Current Assets | 2 | 2.4 | 3.19 | 4.21 | 4.27 | 1.63 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 0 | 0.01 | 0.02 | Upgrade
|
| Total Assets | 2 | 2.4 | 3.19 | 4.21 | 4.27 | 1.64 | Upgrade
|
| Accounts Payable | 0.08 | 0.07 | 0.12 | 0.18 | 0.05 | 0.04 | Upgrade
|
| Accrued Expenses | 0.03 | 0.1 | 0.06 | 0.27 | 0.15 | 0.22 | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.04 | - | Upgrade
|
| Total Current Liabilities | 0.11 | 0.17 | 0.18 | 0.45 | 0.24 | 0.27 | Upgrade
|
| Total Liabilities | 0.11 | 0.17 | 0.18 | 0.45 | 0.24 | 0.27 | Upgrade
|
| Common Stock | 81.73 | 81.54 | 81.54 | 80.24 | 78.95 | 74.37 | Upgrade
|
| Retained Earnings | -80.75 | -79.89 | -79.08 | -80.73 | -78.74 | -76.79 | Upgrade
|
| Comprehensive Income & Other | 0.91 | 0.57 | 0.56 | 4.25 | 3.83 | 3.79 | Upgrade
|
| Shareholders' Equity | 1.89 | 2.23 | 3.01 | 3.76 | 4.03 | 1.38 | Upgrade
|
| Total Liabilities & Equity | 2 | 2.4 | 3.19 | 4.21 | 4.27 | 1.64 | Upgrade
|
| Net Cash (Debt) | 1.88 | 2.32 | 3.11 | 4.11 | 4.24 | 1.61 | Upgrade
|
| Net Cash Growth | -21.76% | -25.39% | -24.39% | -3.02% | 162.92% | -40.51% | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Filing Date Shares Outstanding | 1,728 | 1,687 | 1,687 | 1,636 | 1,285 | 571.44 | Upgrade
|
| Total Common Shares Outstanding | 1,728 | 1,687 | 1,687 | 1,560 | 1,285 | 571.44 | Upgrade
|
| Working Capital | 1.89 | 2.23 | 3.01 | 3.76 | 4.03 | 1.36 | Upgrade
|
| Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Tangible Book Value | 1.89 | 2.23 | 3.01 | 3.76 | 4.03 | 1.38 | Upgrade
|
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Machinery | - | - | - | - | 0.01 | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.